Trastuzumab - StatPearls

Trastuzumab - StatPearls trastuzumab Comment: Trastuzumab is a humanized IgG1κ monoclonal antibody targeting HER2 Annotated peptide sequences for this antibody are available from its IMGTmAb-DB trastuzumab A study of more than 4000 patients, published in 2014, showed that adding trastuzumab to chemotherapy led to a 37% relative improvement in

trastuzumab Key Message The ShortHER trial failed to demonstrate the non-inferiority of 9 weeks versus 1 year of adjuvant trastuzumab combined with chemotherapy The short

trastuzumab Trastuzumab is a biologic antineoplastic agent that, at the time of its FDA approval in 1998, was among the first available targeted chemotherapies  ของยาตัวใหม่ที่กระตุ้นให้เกิดการแพ้ยาในขณะที่ยาต้นแบบไ ม่มี เป็นต้น Trastuzumab เป็น humanized monoclonal antibody ที่ออกฤทธิ์ต้าน HER2 ซึ่งเป็น growth factor receptor